Imperial College London

ProfessorSebastianJohnston

Faculty of MedicineNational Heart & Lung Institute

Asthma UK Clinical Chair
 
 
 
//

Contact

 

+44 (0)7931 376 544s.johnston

 
 
//

Assistant

 

Mr Christophe Tytgat +44 (0)20 7594 3849

 
//

Location

 

343Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Menditto:2019:10.1111/cea.13333,
author = {Menditto, E and Costa, E and Midão, L and Bosnic-Anticevich, S and Novellino, E and Bialek, S and Briedis, V and Mair, A and Rajabian-Soderlund, R and Arnavielhe, S and Bedbrook, A and Czarlewski, W and Annesi-Maesano, I and Anto, JM and Devillier, P and De, Vries G and Keil, T and Sheikh, A and Orlando, V and Larenas-Linnemann, D and Cecchi, L and De, Feo G and Illario, M and Stellato, C and Fonseca, J and Malva, J and Morais-Almeida, M and Pereira, AM and Todo-Bom, A and Kvedariene, V and Valiulis, A and Bergmann, KC and Klimek, L and Mösges, R and Pfaar, O and Zuberbier, T and Cardona, V and Mullol, J and Papadopoulos, NG and Prokopakis, EP and Bewick, M and Ryan, D and Roller-Wirnsberger, RE and Tomazic, PV and Cruz, AA and Kuna, P and Samolinski, B and Fokkens, WJ and Reitsma, S and Bosse, I and Fontaine, JF and Laune, D and Haahtela, T and Toppila-Salmi, S and Bachert, C and Hellings, PW and Melén, E and Wickman, M and Bindslev-Jensen, C and Eller, E and O'Hehir, RE and Cingi, C },
doi = {10.1111/cea.13333},
journal = {Clinical and Experimental Allergy},
pages = {442--460},
title = {Adherence to treatment in allergic rhinitis using mobile technology. the mask study},
url = {http://dx.doi.org/10.1111/cea.13333},
volume = {49},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - BACKGROUND: Mobile technology may help to better understand the adherence to treatment MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centered ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. OBJECTIVES: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. METHODS: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from January 1, 2016 to August 1, 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. RESULTS: 12,143 users were registered. 6,949 users reported at least one VAS data recording. Among them, 1,887 users reported ≥ 7 VAS data. 1,195 subjects were included in the analysis of adherence. 136 (11.28%) users were adherent (MPR ≥70% and PDC ≤ 1.25), 51 (4.23%) were partly adherent (MPR ≥70% and PDC =1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR<70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. CONCLUSION AND CLINICAL RELEVANCE: Adherence to treatment is low. The relative efficacy of continuous versus on-demand treatment for AR symptoms is still a matter of debate.This study shows an approach for measuring retrospective adherence based on a mobile app. This represent a novel approach also for analyzing medication taking behavior in a real-world setting. This article is protected by copyright. All rights reserved.
AU - Menditto,E
AU - Costa,E
AU - Midão,L
AU - Bosnic-Anticevich,S
AU - Novellino,E
AU - Bialek,S
AU - Briedis,V
AU - Mair,A
AU - Rajabian-Soderlund,R
AU - Arnavielhe,S
AU - Bedbrook,A
AU - Czarlewski,W
AU - Annesi-Maesano,I
AU - Anto,JM
AU - Devillier,P
AU - De,Vries G
AU - Keil,T
AU - Sheikh,A
AU - Orlando,V
AU - Larenas-Linnemann,D
AU - Cecchi,L
AU - De,Feo G
AU - Illario,M
AU - Stellato,C
AU - Fonseca,J
AU - Malva,J
AU - Morais-Almeida,M
AU - Pereira,AM
AU - Todo-Bom,A
AU - Kvedariene,V
AU - Valiulis,A
AU - Bergmann,KC
AU - Klimek,L
AU - Mösges,R
AU - Pfaar,O
AU - Zuberbier,T
AU - Cardona,V
AU - Mullol,J
AU - Papadopoulos,NG
AU - Prokopakis,EP
AU - Bewick,M
AU - Ryan,D
AU - Roller-Wirnsberger,RE
AU - Tomazic,PV
AU - Cruz,AA
AU - Kuna,P
AU - Samolinski,B
AU - Fokkens,WJ
AU - Reitsma,S
AU - Bosse,I
AU - Fontaine,JF
AU - Laune,D
AU - Haahtela,T
AU - Toppila-Salmi,S
AU - Bachert,C
AU - Hellings,PW
AU - Melén,E
AU - Wickman,M
AU - Bindslev-Jensen,C
AU - Eller,E
AU - O'Hehir,RE
AU - Cingi,C
AU - Gemiciolu,B
AU - Kalayci,O
AU - Ivancevich,JC
AU - Bousquet,J
AU - MASK,group
DO - 10.1111/cea.13333
EP - 460
PY - 2019///
SN - 0954-7894
SP - 442
TI - Adherence to treatment in allergic rhinitis using mobile technology. the mask study
T2 - Clinical and Experimental Allergy
UR - http://dx.doi.org/10.1111/cea.13333
UR - https://www.ncbi.nlm.nih.gov/pubmed/30597673
UR - http://hdl.handle.net/10044/1/67564
VL - 49
ER -